AccessPak for HIV PEP Expanded with Kaletra and Remifentanil Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Remifentanil Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: remifentanil
Brand name: Ultiva
Synonyms: Remifentanil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Reminyl
- AccessPak for HIV PEP Expanded with Kaletra-Reminyl ER
- AccessPak for HIV PEP Expanded with Kaletra-Remodulin
- AccessPak for HIV PEP Expanded with Kaletra-Remodulin injection
- AccessPak for HIV PEP Expanded with Kaletra-Remular-S
- AccessPak for HIV PEP Expanded with Kaletra-Renacidin
- Remifentanil Intravenous-AccessPak for HIV PEP Expanded with Viracept
- Remifentanil Intravenous-Accolate
- Remifentanil Intravenous-Accretropin
- Remifentanil Intravenous-Accucaine
- Remifentanil Intravenous-AccuHist Drops
- Remifentanil Intravenous-AccuHist PDX Drops